Filter
683
Filtered Results: 683
Text search:
antígenos
Featured
Recommendations
70
New Publications
150
Language
Document type
No document type
330
Guidelines
178
Studies & Reports
78
Manuals
39
Strategic & Response Plan
20
Fact sheets
16
Situation Updates
9
Training Material
6
Brochures
2
Infographics
2
Videos
2
Resource Platforms
1
Countries / Regions
India
39
Brazil
28
Latin America and the Carribbean
26
Global
22
Argentina
17
Kenya
16
Africa
14
Uganda
12
Colombia
12
Germany
11
Tanzania
11
Bolivia
11
South Africa
10
Paraguay
10
Nigeria
9
East and Southern Africa
9
Liberia
8
Nepal
8
Ethiopia
7
Philippines
7
Malawi
7
El Salvador
7
Sierra Leone
6
Rwanda
6
Peru
6
Chile
6
West and Central Africa
6
Western and Central Europe
6
Bangladesh
5
Ecuador
5
Venezuela
5
Zimbabwe
4
Mozambique
4
Middle East and North Africa
4
South–East Asia Region
4
Congo, Democratic Republic of
3
USA
3
Ghana
3
Zambia
3
Cambodia
3
Namibia
3
Ukraine
3
Botswana
3
Lesotho
3
Myanmar / Burma
3
Cameroon
2
Pakistan
2
South Sudan
2
Angola
2
Guatemala
2
Spain
2
Guinea
1
Burkina Faso
1
Senegal
1
Somalia
1
Afghanistan
1
Syria
1
Indonesia
1
Sudan
1
Dominican Republic
1
Cuba
1
Honduras
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Western Pacific Region
1
Timor Leste/ East Timor
1
Russia
1
North America
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
296
Clinical Guidelines
104
Pharmacy & Technologies
32
Public Health
27
Women & Child Health
17
Key Resources
6
Capacity Building
3
Toolboxes
COVID-19
122
TB
89
NTDs
63
HIV
48
Rapid Response
31
Mental Health
15
Ebola
11
Polio
11
Refugee
10
Pharmacy
10
Planetary Health
7
Cholera
4
Natural Hazards
4
Zika
4
Caregiver
4
NCDs
4
AMR
3
Conflict
2
Global Health Education
2
Specific Hazards
1
Health Financing Toolbox
1
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
During the year 2022, COVID-19 continued to be a significant challenge in Eritrea as in many other countries across the world. As COVID-19 devastated communities around the world, WHO worked with the MoH to strengthen the National and Sub-National health systems in order to meet community needs and ...
La leishmaniasis es una enfermedad tropical desatendida sensible
al clima, trasmitida por la picadura de insectos flebótomos y
se calcula que amenaza a mil millones de personas en todo el mundo.
Esta enfermedad altamente compleja se presenta de varias formas
clínicas, causadas por 20 especies ...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
